Загрузка...
Exportin 1 inhibition as antiviral therapy
Coronavirus 2019 (COVID-19; caused by Severe Acute Respiratory Syndrome Coronavirus 2; SARS-CoV-2) is a currently global health problem. Previous studies showed that blocking nucleocytoplasmic transport with exportin 1 (XPO1) inhibitors originally developed as anticancer drugs can quarantine key vir...
Сохранить в:
| Опубликовано в: : | Drug Discov Today |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Elsevier Ltd.
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7305737/ https://ncbi.nlm.nih.gov/pubmed/32569833 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.drudis.2020.06.014 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|